Company Announcements

Evotec’s Precision Medicine Platforms Signal New Opportunities for CDMOs

Evotec SE’s precision medicine platforms showcased at Capital Markets Day have major implications for CDMOs in areas from contract development to digital manufacturing and…

December 19, 2025

Company Announcements

Evotec SE Q3 2023 Results Reveal CDMO Sector Impact and Strategic Outlook

Evotec SE's nine-month 2023 financial results highlight key trends and strategies shaping the CDMO landscape, from capacity expansion to technological innovation.

December 19, 2025

Company Announcements

Evotec Secures SBTi Approval for Emissions Reduction Targets and Its Implications for CDMOs

Evotec’s recent approval from the Science Based Targets initiative for near term emissions goals underscores a growing sustainability focus within the CDMO industry. Discover…

December 18, 2025

Company Announcements

Evotec and Dewpoint Therapeutics Forge Strategic Oncology Partnership: CDMO Implications

Analysis of the Evotec-Dewpoint oncology partnership through a CDMO lens, highlighting development, manufacturing, outsourcing and regulatory impacts.

December 18, 2025

Company Announcements

Evotec SE to Announce Nine-Month 2023 Results: Implications for the CDMO Sector

Evotec SE’s upcoming nine-month 2023 financial report may signal shifts in the CDMO landscape. We explore its impact on contract development, manufacturing capacity, supply…

December 16, 2025

Company Announcements

How Sharp’s Acquisition of BSM Strengthens CDMO Sterile Manufacturing Capabilities

Explore the strategic impact of Sharp’s acquisition of Berkshire Sterile Manufacturing on sterile fill-finish capacity, regulatory synergies, and CDMO market dynamics.

November 23, 2025

Company Announcements

Evotec Joins iCARE4CVD Consortium to Shape CDMO Landscape in Cardiovascular R&D

Evotec’s entry into the international iCARE4CVD consortium underscores emerging opportunities for CDMOs in cardiovascular disease R&D, covering manufacturing scale-up, data analytics integration, and strategic…

November 23, 2025

Company Announcements

etherna Appoints Bernard Sagaert as CEO and Marijn Dekkers as Chairman: Implications for the CDMO Sector

Biotech firm etherna names Bernard Sagaert as CEO and Marijn Dekkers as Chairman, reshaping its CDMO partnership strategies, capacity planning, and regulatory focus.

November 23, 2025

Company Announcements

Evotec and Amplitude Ventures Partnership Signals New CDMO Strategies for Pre-Amp Innovation

Evotec SE and Amplitude Ventures have formed a BRIDGE partnership to launch Pre-Amp, a venture studio focusing on precision medicine. This article examines how…

November 23, 2025

Company Announcements

Evotec Launches Cyprotex e-Store for ADME-Tox Ordering: Implications for CDMOs

Evotec’s Cyprotex e-Store simplifies ADME-Tox service ordering through an online portal, offering CDMOs enhanced transparency, efficiency, and regulatory support.

November 23, 2025